New evidence review uncovers ‘significant’ link between particulate matter and dementia
Information from 17 existing studies was reviewed, involving 91 million people
Read More
Tag: Neurology journal
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
